Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc Abacavir Study – Effect on Endothelial Recovery
2010-022641-25Phase 4Completed
- Sponsor
- University Medical Center Utrecht
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of maraviroc in human immunodeficiency virus infection (HIV), sponsored by University Medical Center Utrecht. Primary endpoint: Change in flow-mediated dilatation (FMD) of the brachial artery after 8 weeks of maraviroc treatment. Started Jun 2011; status: completed.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2010-022641-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022641-25.